BioCentury
ARTICLE | Strategy

Accelerating Flatiron

How Roche acquisition accelerates expansion of Flatiron’s real-world data platform

March 9, 2018 4:35 PM UTC

Roche isn’t saying much about how it approached the decision to shell out $1.9 billion to acquire the 87% of Flatiron Health Inc. it didn’t already own. But it appears that Flatiron would have needed to scale back or at least slow down development of its real-world data platform as a stand-alone company.

Since Roche is counting on those data to accelerate development of its cancer pipeline, ensuring that Flatiron had the resources to develop the platform quickly made strategic sense...

BCIQ Company Profiles

Flatiron Health Inc.

Roche